The policy, called Share 35, preferentially offers kidneys from deceased donors younger than age 35 to children who need a kidney transplant. While a kidney from a living donor is preferable, a kidney from a deceased donor can save a child's life.
Anyhow, it is good news for younger patients with kidney disease. New policy means younger kidney disease patients may enjoy colorful life by kidney transplant. While just as the patients told us, it has become more and more difficult to get a suitable kidney. So kidney transplant isn’t a very good choice nowadays.
Generally speaking, patients with kidney disease will choose kidney transplant when they have no other better choices. Here I would like to share an effective treatment with kidney disease patients, which is Immunotherapy in Shijiazhuang Kidney Disease Hospital.
Immunotherapy are very special, powerful cells found in both humans and non-human animals. They have been called the centrepieces of regenerative medicine – medicine that involves growing new cells, tissues and organs to replace or repair those damaged by injury, disease or aging.
Immunotherapy are the precursors of all cells in the human body. What makes Immunotherapy cells special is that they are regenerative and malleable. They have the ability to replicate themselves and to repair and replace other tissues in the human body. Some tissues, like skin, need constant renewal, which could not take place without skin Immunotherapys. Other Immunotherapys repair damage to the body’s tissues, for example, rebuilding damaged or degenerating muscle tissue. So Immunotherapy therapy can help patients recover the damaged cells in the kidney.
Is kidney transplant good choice for patients? Kidney transplant or Immunotherapy therapy? you must have answer.
